ClinConnect ClinConnect Logo
Search / Trial NCT06562556

Impact of Breather Device on Ventilatory Effort in Patient With MTMD

Launched by CAIRO UNIVERSITY · Aug 17, 2024

Trial Information

Current as of September 10, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a device called the breather on patients suffering from myogenic temporomandibular joint disorders (TMD). TMD is a condition that affects the jaw and can cause pain in the jaw muscles, difficulties in moving the jaw, ear pain, headaches, and other issues. The trial aims to see if using the breather device can help improve breathing effort and also positively impact the position of the head and neck, as well as the overall oral health of participants.

To be eligible for the study, participants must be women aged between 20 and 40 who have specific symptoms of TMD, such as teeth grinding or mouth breathing. They should also meet certain health criteria, including a specific body ratio and angle related to head and neck position. The trial is not yet recruiting participants, but those who join can expect to use the breather device and contribute to understanding how it might help individuals with TMD. All participants will need to give their consent before joining the study.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • * Inclusion criteria:
  • 1. Sixty female patients who fulfilled the RDC/TMD criteria of myofascial pain and the presence of parafunctional habits, such as bruxism, teeth grinding, mouth breathing, and lip biting.
  • 2. The Patient's ages will range from 20 to 40 years.
  • 4- Patients with a waist-height ratio measuring less than 0.5. 5- Patients with a craniocervical angle measuring from 30 to 50° (Bo-Been et al., 2016).
  • 6- the patients have points from 20-65 on the Fonseca Anamnestic Index (FAI) 7- the patients have the willingness to participate in this study. 8- All patients will sign a consent form before starting the study.
  • Exclusion Criteria:
  • Patients will meet one of the following criteria will be excluded from the study:
  • 1. patients undergo surgery or trauma in the orofacial region; systemic or degenerative odontologic disease.
  • 2. The patient has Surgery or trauma in the spine and upper limb.
  • 3. Patients suffering from rheumatic diseases and other severe comorbidities.
  • 4. Patients suffering from any respiratory diseases (restrictive, obstructive, suppurative diseases).
  • 5. Patients suffering from neurological disorders affecting respiratory muscles or any muscular dystrophies

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported